Online citations, reference lists, and bibliographies.
← Back to Search

Targeted Gene Delivery To Selected Liver Segments Via Isolated Hepatic Perfusion.

Hiroyasu Kinoshita, A. Watanabe, S. Hisayasu, S. Suzuki, Takashi Shimada
Published 2010 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
BACKGROUND Development of targeted gene transfer technologies is essential for in vivo gene therapy. In this study, we examined the feasibility of physically targeting an adenoviral vector to selected liver segments in rats by isolating the hepatic perfusion (IHSP) and clamping the portal vein between the upper and lower segments. MATERIALS AND METHODS The rats were divided into two groups: IHSP group and the inferior vena cava (IVC) group. The adenoviral vector, which harbored the beta-galactosidase (beta-gal) gene, was administered via the portal vein, after which unbound vector particles were washed out with phosphate-buffered saline (PBS) and removed via the cannulated inferior vena cava (IVC) in IHSP group, while the IVC group received the transgene directly via the IVC without isolation of the hepatic perfusion. RESULTS With this configuration (IHSP group), >99% of the beta-gal activity was limited to the targeted hepatic lobes, findings which were confirmed by histochemical staining with X-gal. We also found there to be significant differences in transgene expression among the hepatic lobes in the IVC group. CONCLUSIONS Taken together, these results indicate that the IHSP technique is useful for local gene delivery to selected liver segments, and that when evaluating the efficacy of IHSP in the treatment of liver disease (e.g., nonresectable tumors), interlobar differences must be given careful consideration to ensure that sufficient drug or vector is delivered to all targeted hepatic lobes.
This paper references
Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver.
K. Ohashi (2005)
A simple and efficient method for purification of infectious recombinant adenovirus.
Y. Kanegae (1994)
Adenovirus-Mediated Gene Transfer into Selected Liver Segments Using a Vascular Exclusion Technique
B. Scholl (2001)
In vitro and in vivo comparative study of chimeric liver-specific promoters.
M. G. Kramer (2003)
Efficiency of adenovirus-mediated gene transfer into hepatocytes by liver asanguineous perfusion method
Y. Futagawa (2000)
Tumor necrosis factor α plays a central role in immune-mediated clearance of adenoviral vectors
K. Elkon (1997)
Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer.
K. Drazan (1995)
Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.
J. Rothbarth (2004)
Liver gene therapy: advances and hurdles
T. Nguyen (2004)
Molecular basis of the inflammatory response to adenovirus vectors
Q. Liu (2003)
Gene therapy in in vivo isolated perfusion models.
B. van Etten (2005)
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Niwa Hitoshi (1991)
Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver
Wk de Roos (1997)
Efficient selection for high-expression transfectants with a novel eukaryotic vector.
H. Niwa (1991)
Inhibition of Tumor Necrosis Factor Alpha by an Adenovirus-Encoded Soluble Fusion Protein Extends Transgene Expression in the Liver and Lung
Y. Peng (1999)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.
S. Raper (2003)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar